Cargando…
An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infection
Zika virus (ZIKV), an arbovirus transmitted by mosquitoes, was identified as a cause of congenital disease during a major outbreak in the Americas in 2016. Vaccine design strategies relied on limited available isolate sequence information due to the rapid response necessary. The first-generation ZIK...
Autores principales: | Bollman, Brooke, Nunna, Naveen, Bahl, Kapil, Hsiao, Chiaowen Joyce, Bennett, Hamilton, Butler, Scott, Foreman, Bryant, Burgomaster, Katherine E., Aleshnick, Maya, Kong, Wing-Pui, Fisher, Brian E., Ruckwardt, Tracy J., Morabito, Kaitlyn M., Graham, Barney S., Dowd, Kimberly A., Pierson, Theodore C., Carfi, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119314/ https://www.ncbi.nlm.nih.gov/pubmed/37080988 http://dx.doi.org/10.1038/s41541-023-00656-4 |
Ejemplares similares
-
Development of a potent Zika virus vaccine using self-amplifying messenger RNA
por: Luisi, Kate, et al.
Publicado: (2020) -
Phenotype and Hierarchy of Two Transgenic T Cell Lines Targeting the Respiratory Syncytial Virus K(d)M2(82-90) Epitope Is Transfer Dose-Dependent
por: Morabito, Kaitlyn M., et al.
Publicado: (2016) -
Quantitative and Qualitative Deficits in Neonatal Lung-Migratory Dendritic Cells Impact the Generation of the CD8+ T Cell Response
por: Ruckwardt, Tracy J., et al.
Publicado: (2014) -
Neonatal mice possess two phenotypically and functionally distinct lung-migratory CD103+ dendritic cell populations following respiratory infection
por: Ruckwardt, Tracy J, et al.
Publicado: (2017) -
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials
por: Gaudinski, Martin R, et al.
Publicado: (2018)